AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75N93026C00012ARISAN THERAPEUTICS INC
Overview
Award facts
- Net obligations
- $2.93M
- $2,933,547of $23.88M potential value
- Period of performance
- Aug 3, 2026 to Jun 30, 2027
- Ends in 7 months
- Modifications
- 0
- Latest action Jul 29, 2026
- Contract type
- Definitive contract
- PIID 75N93026C00012
Description of requirement
TO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION.
Dates and value
- Award date
- Signed on Jul 29, 2026
- Current value
- $2,933,547Base and exercised options
- Potential value (if all options are exercised)
- $23,878,987
Obligations by fiscal year of action
- FY2026: $2,933,547
Total across 1 fiscal year: $2,933,547
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 29, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationCARLSBAD, CA
UEIPYRKTQPNVJZ8
CAGE code616D2
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyARISAN THERAPEUTICS INC
Business types and certifications
Self-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- 075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Carlsbad, San Diego County, California 92008-4401
- Congressional district (place of performance)
- CA-49As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 20
Solicitation and notices
- Solicitation ID
- HHS-NIH-NIAID-BAA2025-1
- Solicitation date
- Nov 22, 2024
- Notices
- Award Notice posted Aug 3, 2026
- Award Notice posted Aug 3, 2026
- Award Notice posted Jul 17, 2026
- Solicitation posted Jan 16, 2025
- Solicitation posted Jan 10, 2025
- Solicitation posted Dec 27, 2024
- Solicitation posted Dec 18, 2024
- Solicitation posted Dec 11, 2024
- Solicitation posted Dec 3, 2024
- Solicitation posted Nov 22, 2024
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jul 29, 2026Base obligation at award: $2,933,547
- Latest action
- Jul 29, 2026 — Base awardModification 0; obligation change +$2,933,547
- Actions by type
- Base award1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $2,933,547
- Latest action: change in base and all options
- $23,878,987
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 1
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2026/2026-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression